The present issue of this journal focuses on the two novel antiviral agents now available against hepatitis B virus (HBV) infection and certain special situations in relation to HBV infection which ar... |
|
Around 2 billion people are infected by hepatitis B virus (HBV) worldwide of which 360 million persons suffer chronic infection with HBV.[1] Raised ALT is found in 38% where as 62% have normal ALT. Al... |
|
Introduction
Hepatitis B is the leading cause of viral hepatitis in the developing world, including India and southeast Asia. At least 350 million people are infected with chronic hepa... |
